A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
Clinical trial NCT04278924 · COMPLETED
Trial details
- NCT number
- NCT04278924
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-09
- Primary completion
- 2024-04-29
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.